Concepedia

Paulo Vidal Campregher

PV

Statistics

Publications

19

Citations

2.6K

H-Index

15

Active since

2004

Affiliations

Hospital Israelita Albert Einstein(Current)

Fred Hutch Cancer Center

University of Washington

Universidade Estadual de Campinas (UNICAMP)

Universidade de São Paulo

Paulo Vidal Campregher is an author at Hospital Israelita Albert Einstein specializing in medicine, hematology, and cancer research.

ORCID

Top concepts

Publications per year

2004–2022

19

Publications

19

Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells

Harlan Robins, Paulo Vidal Campregher, Santosh K. Srivastava et al. · Blood · 2009 · 1.2K citations · Full text

Overlap and Effective Size of the Human CD8 <sup>+</sup> T Cell Receptor Repertoire

Harlan Robins, S. K. Srivastava, Paulo Vidal Campregher et al. · Science Translational Medicine · 2010 · 417 citations · Full text

Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD

Afonso Celso Vigorito, Paulo Vidal Campregher, Barry E. Storer et al. · Blood · 2009 · 260 citations · Full text

Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)

Peter Horak, Malachi Griffith, Arpad Danos et al. · Genetics in Medicine · 2022 · 211 citations · Full text

, , +11

HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib

Sai‐Hong Ignatius Ou, Alexa B. Schrock, Eduard V. Bocharov et al. · Journal of Thoracic Oncology · 2016 · 110 citations · Full text

1–5 of 19